These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 33425715)
21. Standardized uptake value and metabolic tumor volume measured by ¹⁸F FDG PET/CT are sensitive biomarkers for the presence of lymph node metastasis in patients with cervical carcinoma. Vural GU; Akkas BE; Demirel BB Rev Esp Med Nucl Imagen Mol; 2014; 33(5):268-73. PubMed ID: 25018135 [TBL] [Abstract][Full Text] [Related]
22. Correlation study on 18F-FDG PET/CT metabolic characteristics of primary lesion with clinical stage in lung cancer. Hu WD; Wang HC; Wang YB; Cui LL; Chen XH Q J Nucl Med Mol Imaging; 2021 Jun; 65(2):172-177. PubMed ID: 30916535 [TBL] [Abstract][Full Text] [Related]
23. Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma. Koyasu S; Nakamoto Y; Kikuchi M; Suzuki K; Hayashida K; Itoh K; Togashi K AJR Am J Roentgenol; 2014 Apr; 202(4):851-8. PubMed ID: 24660716 [TBL] [Abstract][Full Text] [Related]
24. Prediction of lymph node metastasis by PET/CT metabolic parameters in patients with esophageal squamous cell carcinoma. Xu M; Wang L; Ouyang M; Lin J; Wang L; Zheng X; Miao S; Tang K Nucl Med Commun; 2019 Sep; 40(9):933-939. PubMed ID: 31343610 [TBL] [Abstract][Full Text] [Related]
25. Prediction of distant metastasis and survival in adenoid cystic carcinoma using quantitative Lim WS; Oh JS; Roh JL; Kim JS; Kim SJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2018 Feb; 77():98-104. PubMed ID: 29362133 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients. Zschaeck S; Li Y; Lin Q; Beck M; Amthauer H; Bauersachs L; Hajiyianni M; Rogasch J; Ehrhardt VH; Kalinauskaite G; Weingärtner J; Hartmann V; van den Hoff J; Budach V; Stromberger C; Hofheinz F PLoS One; 2020; 15(7):e0236841. PubMed ID: 32730364 [TBL] [Abstract][Full Text] [Related]
27. The predictive recurrence value of MTV-s as an 18F-FDG PET/CT index in patients with IIB-IVA cervical cancer. Deng C; Ding D; Wang M Postgrad Med; 2021 May; 133(4):436-443. PubMed ID: 33620285 [No Abstract] [Full Text] [Related]
28. Tumor-stroma ratio is a crucial histological predictor of occult cervical lymph node metastasis and survival in early-stage (cT1/2N0) oral squamous cell carcinoma. Huang S; Cai H; Song F; Zhu Y; Hou C; Hou J Int J Oral Maxillofac Surg; 2022 Apr; 51(4):450-458. PubMed ID: 34412929 [TBL] [Abstract][Full Text] [Related]
29. Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer. Park SY; Yoon JK; Park KJ; Lee SJ Cancer Imaging; 2015 Dec; 15():21. PubMed ID: 26694918 [TBL] [Abstract][Full Text] [Related]
30. Predictive value of 18 Xue J; Zheng J; Guo H; Wang X; Han A Mol Clin Oncol; 2015 Jan; 3(1):109-114. PubMed ID: 25469279 [TBL] [Abstract][Full Text] [Related]
31. Metabolic parameters with different thresholds for evaluating tumor recurrence and their correlations with hematological parameters in locally advanced squamous cell cervical carcinoma: an observational Du S; Sun H; Gao S; Xin J; Lu Z Quant Imaging Med Surg; 2019 Mar; 9(3):440-452. PubMed ID: 31032191 [TBL] [Abstract][Full Text] [Related]
32. Activin A immunoexpression as predictor of occult lymph node metastasis and overall survival in oral tongue squamous cell carcinoma. Kelner N; Rodrigues PC; Bufalino A; Fonseca FP; Santos-Silva AR; Miguel MC; Pinto CA; Leme AF; Graner E; Salo T; Kowalski LP; Coletta RD Head Neck; 2015 Apr; 37(4):479-86. PubMed ID: 24677273 [TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma. Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144 [TBL] [Abstract][Full Text] [Related]
34. Prognostic value of metabolic tumor volume measured by 18F-FDG PET/CT in advanced-stage squamous cell carcinoma of the larynx and hypopharynx. Park GC; Kim JS; Roh JL; Choi SH; Nam SY; Kim SY Ann Oncol; 2013 Jan; 24(1):208-14. PubMed ID: 23002280 [TBL] [Abstract][Full Text] [Related]
35. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis. Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018 [TBL] [Abstract][Full Text] [Related]
36. Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer. Murphy JD; La TH; Chu K; Quon A; Fischbein NJ; Maxim PG; Graves EE; Loo BW; Le QT Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):514-21. PubMed ID: 20646870 [TBL] [Abstract][Full Text] [Related]
37. Machine learning-based MRI texture analysis to predict occult lymph node metastasis in early-stage oral tongue squamous cell carcinoma. Yuan Y; Ren J; Tao X Eur Radiol; 2021 Sep; 31(9):6429-6437. PubMed ID: 33569617 [TBL] [Abstract][Full Text] [Related]
38. [Value of (18)F-FDG PET-CT imaging to predict epidermal growth factor receptor mutations in patients with lung squamous cell carcinoma]. Zhao CY; Deng XY; Wang HS; Cao GP; Ding JN; Ding CY Zhonghua Zhong Liu Za Zhi; 2021 Jul; 43(7):795-800. PubMed ID: 34289575 [No Abstract] [Full Text] [Related]
39. Prognostic value of volumetric FDG PET/CT parameters in patients with oral tongue squamous cell carcinoma who were treated by superselective intra-arterial chemoradiotherapy. Suzuki-Shibata S; Yamamoto Y; Yoshida T; Mizoguchi N; Nonaka T; Kubota A; Narimatsu H; Miyagi Y; Kobayashi T; Kaneta T; Inoue T Jpn J Radiol; 2017 Dec; 35(12):740-747. PubMed ID: 29039110 [TBL] [Abstract][Full Text] [Related]
40. Feasibility of Submandibular Gland Preservation in cT1-2N0 Squamous Cell Carcinoma in the Floor of the Mouth. Du W; Fang Q; Liu S; Chen D; Luo R; Zhang X Front Oncol; 2020; 10():579. PubMed ID: 32373538 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]